Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Dear DWAC Stock Fans, Mark Your Calendars for Dec. 15

Investors in Digital World Acquisition and DWAC stock appear to be pricing in some positive news to be announced tomorrow.

Goodbye, PFOF? What to Know About SEC Changes as HOOD, VIRT Stock Fall.

Investors in financial services company Virtu Financial and VIRT stock are pricing in uncertainty around various SEC proposals today.

3 EV Stocks Worth Buying Before They Accelerate in 2023

These three top EV stocks provide long-term investors with the kind of growth at a reasonable price that's hard to get these days.

3 High-Growth Stocks With Multibagger Potential by 2025

For traders looking to put some capital to work in potential multibagger high-growth stocks, start with these three names.

PRTY Stock Alert: Is Party City Going Bankrupt?

Shareholders in Party City and PRTY stock certainly have a lot to think about, as the company's bondholders gather together.

AMC Entertainment’s APE Stock Heats Up Ahead of ‘Avatar’ Launch

Today, investors in AMC Entertainment's preferred APE stock are seeing big gains amid a catch-up rally in this meme stock.

Bakkt Layoffs 2022: What to Know About the Latest BKKT Job Cuts

Shares of BKKT stock are increasing today on news that this company is the latest to impose job cuts. Here's the latest on the Bakkt layoffs.

Why Is Meta Materials (MMAT) Stock Down 25% Today?

Investors in beaten down Meta Materials and MMAT stock have even more to chew on today, following a revised notice from FINRA.

Why Is Ambrx (AMAM) Stock Up 400% Today?

Today, shareholders in early-stage biotech company Ambrx and AMAM stock are seeing significant gains in this volatile session.

Why Elon Musk Thinks Lucid (LCID) Stock Is About to Die

Today, investors in early-stage electric vehicle maker Lucid and LCID stock are seeing significant selling pressure from an Elon Musk tweet.